American academy of pain medicine ethics council statement on conflicts of interest: Interaction between physicians and industry in pain medicine

Pain Medicine

Volumn 11, Issue 2, 2010, Pages 257-262

  Dubois, Michel Y ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

Conflict of interest; Disclosure; Industry; Medical ethics

Indexed keywords

ARTICLE; CONFLICT OF INTEREST; CONTINUING EDUCATION; DRUG INDUSTRY; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HUMAN; INTERPERSONAL COMMUNICATION; INVESTMENT; LEADERSHIP; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL SOCIETY; PAIN; PEER REVIEW; PHYSICIAN ATTITUDE; PROFESSIONAL COMPETENCE; PROFESSIONAL PRACTICE; RESEARCH ETHICS; SOCIAL INTERACTION; SYSTEMATIC ERROR; UNITED STATES;

EID: 75249103828     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2009.00739.x     Document Type: Article

References (13)

1. Brennan T, Rothman D, Blank L. Health industry practices that create conflicts of interest. A policy proposal for academic medical centers. JAMA 2006, 295:429-33.
2. Loewenstein G, Korn D, Ehringhaus S. The behavioral economics perspective. The Scientific Basis of Influence and Reciprocity: A Symposium 2007, http://www.aamc.com, In, eds., Washington, DC, AAMC, Available at: (accessed November 8, 2009)
3. Montague R, Korn D, Ehringhaus S. The perspective from neuroscience. The Scientific Basis of Influence and Reciprocity: A Symposium 2007, http://www.aamc.com, In, eds., Washington, DC, AAMC, Available at: (accessed November 8, 2009)
4. Morgan M, Dana J, Lewenstein G. Interactions of doctors with the pharmaceutical industry. J Med Ethics 2006, 32:559-63.
5. Scott I. On the need for probity when physicians interact with industry. Int Med J 2006, 36:265-9.
6. Opinion E-8.061: Gifts to Physicians from Industry. 2008, Code of Medical Ethics of the American Medical Association-Committee on Ethical and Judicial Affairs, Chicago, IL, AMA
7. Thompson DF. Understanding financial conflicts of interest. N Engl J Med 1993, 329(8):573-6.
8. Coyle S. Physician-industry relations. Part 2: Organizational issues. Ann Intern Med 2002, 136:403-6.
9. Wall L, Brown D. The high cost of free lunch. Obstet Gynecol 2007, 110:169-73.
10. Brody H. The company we keep: Why physicians should refuse to see pharmaceutical representatives. Ann Fam Med 2005, 3:82-5.
11. Jibson M. Interactions between physicians and industry. A guide for clinicians. Focus 2007, 5:398-406.
12. Bekelman J, Yan L, Gross C. Scope and impact of financial conflicts of interest in biomedical research. JAMA 2003, 289:454-65.
13. Campbell E, Weissman J, Vogeli C. Financial relationships between institutional review board members and industry. N Engl Med 2006, 355:2321-9.